Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Pharm Innov. 2017 Mar 3;12(2):142–154. doi: 10.1007/s12247-017-9274-0

Fig. 5.

Fig. 5

The compatibility studies between CSIC and various excipients conducted by DSC. The melting peak of CSIC did not change when drug was mixed with PVA (a), HPMC K4M (b), and propylene glycol (c) separately. Drug dissolved in PEG 400 (d) and PEG 4000 (e). The melting peak of CSIC has shifted to a lower temperature at 217°C in the presence of glycerin (f), which might indicate some incompatibility issues